Company Ticker News June 29, 2021Top investment strategist David Roche warns the Fed could burst a market 'bubble' 0 0 Share
Company Ticker News June 29, 2021Roche's (RHHBY) Actemra Gets FDA Emergency Nod for COVID-19 0 0 Share
Company Ticker News June 29, 2021Roche's Enspryng Wins European Approval For Spinal Cord, Optic Nerve Inflammation Disorder 0 0 Share
Press Release June 28, 2021Roche's ENSPRYNG approved by European Commission as first and only at-home subcutaneous treatment for neuromyelitis optica spectrum disorder (NMOSD) 0 0 Share
Company Ticker News June 26, 2021Roche's arthritis drug gets authorized as COVID-19 treatment for the severely ill 0 0 Share
Company Ticker News June 26, 2021FDA Gives Emergency Use Nod For Roche's Arthritis Drug Against Severe COVID-19 0 0 Share
Press Release June 26, 2021Roche's Actemra/RoActemra receives U.S. FDA Emergency Use Authorization for the treatment of COVID-19 in hospitalised adults and children 0 0 Share
Press Release June 25, 2021Genentech's Actemra Receives FDA Emergency Use Authorization for the Treatment of COVID-19 In Hospitalized Adults and Children 0 0 Share
Company Ticker News June 25, 2021Roche's (RHHBY) BLA for PDS With Ranibizumab Accepted by FDA 0 0 Share
Press Release June 24, 2021FDA Accepts Application for Genentech's Port Delivery System With Ranibizumab (PDS) for Treatment of Wet Age-Related Macular Degeneration (AMD) 0 0 Share
